For example, beta-blockers, angiotensin-converting enzyme (ACE)-inhibitors or angiotensin II receptor blockers (ARBs), and calcium channel blockers can be preferentially used in patients with prior myocardial infarction, diabetes, and angina, respectively. This evidence concerns the gene ACE and diabetes mellitus.